المؤلفون: Fanqiao M; Department of Hematology, Tianjin Medical University General Hospital, Tianjin, China.; Department of Bone Marrow Transplantation, Beijing Boren Hospital, Beijing, China., Chen X; Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China., Ren X; Department of Hematology, Tianjin Medical University General Hospital, Tianjin, China., Li L; Department of Hematology, Tianjin Medical University General Hospital, Tianjin, China., Wu T; Department of Bone Marrow Transplantation, Beijing Boren Hospital, Beijing, China.

المصدر: Pediatric transplantation [Pediatr Transplant] 2024 May; Vol. 28 (3), pp. e14367. Date of Electronic Publication: 2022 Jul 21.

نوع المنشور: Case Reports

بيانات الدورية: Publisher: Munksgaard Country of Publication: Denmark NLM ID: 9802574 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1399-3046 (Electronic) Linking ISSN: 13973142 NLM ISO Abbreviation: Pediatr Transplant Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation*/adverse effects , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma* , Receptors, Chimeric Antigen* , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/therapy, Male ; Humans ; Child ; T-Lymphocytes ; Antigens, CD19

المؤلفون: Khurana S; From the Division of Hematology/Oncology, University of Arizona Cancer Center, Tucson (Khurana)., Heckman MG; the Departments of Biomedical Statistics and Informatics (Heckman, Cochuyt) and Laboratory Medicine and Pathology (Jiang), and the Division of Hematology and Medical Oncology (Foran), Mayo Clinic Florida, Jacksonville., Craig FE; the Divisions of Hematopathology (Craig) and Hematology and Medical Oncology (Sproat), Mayo Clinic Arizona, Phoenix., Cochuyt JJ; the Departments of Biomedical Statistics and Informatics (Heckman, Cochuyt) and Laboratory Medicine and Pathology (Jiang), and the Division of Hematology and Medical Oncology (Foran), Mayo Clinic Florida, Jacksonville., Greipp P; the Divisions of Laboratory Genetics (Greipp) and Hematology (Litzow), Mayo Clinic, Rochester, Minnesota., Rahman ZA; the Division of Hematology and Medical Oncology, Sanford Roger Maris Cancer Center, Fargo, North Dakota (Rahman)., Sproat LZ; the Divisions of Hematopathology (Craig) and Hematology and Medical Oncology (Sproat), Mayo Clinic Arizona, Phoenix., Litzow M; the Divisions of Laboratory Genetics (Greipp) and Hematology (Litzow), Mayo Clinic, Rochester, Minnesota., Foran JM; the Departments of Biomedical Statistics and Informatics (Heckman, Cochuyt) and Laboratory Medicine and Pathology (Jiang), and the Division of Hematology and Medical Oncology (Foran), Mayo Clinic Florida, Jacksonville., Jiang LJ; the Departments of Biomedical Statistics and Informatics (Heckman, Cochuyt) and Laboratory Medicine and Pathology (Jiang), and the Division of Hematology and Medical Oncology (Foran), Mayo Clinic Florida, Jacksonville.

المصدر: Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2024 Apr 01; Vol. 148 (4), pp. 471-475.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: College of American Pathologists Country of Publication: United States NLM ID: 7607091 Publication Model: Print Cited Medium: Internet ISSN: 1543-2165 (Electronic) Linking ISSN: 00039985 NLM ISO Abbreviation: Arch Pathol Lab Med Subsets: MEDLINE

مواضيع طبية MeSH: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/pathology , Lymphoma* , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/pathology , Lymphoma, B-Cell*, Adult ; Humans ; CD47 Antigen ; Receptors, CCR4 ; Interleukin-3 Receptor alpha Subunit ; T-Lymphocytes/pathology ; Proto-Oncogene Proteins c-bcl-2

المؤلفون: Hussan SS; Biopharmaceuticals and Biomarkers Discovery Lab., School of Biochemistry and Biotechnology, University of the Punjab, Lahore, 54590, Pakistan., Ali MS; Biopharmaceuticals and Biomarkers Discovery Lab., School of Biochemistry and Biotechnology, University of the Punjab, Lahore, 54590, Pakistan., Fatima M; Biopharmaceuticals and Biomarkers Discovery Lab., School of Biochemistry and Biotechnology, University of the Punjab, Lahore, 54590, Pakistan., Altaf M; Biopharmaceuticals and Biomarkers Discovery Lab., School of Biochemistry and Biotechnology, University of the Punjab, Lahore, 54590, Pakistan., Sadaf S; Biopharmaceuticals and Biomarkers Discovery Lab., School of Biochemistry and Biotechnology, University of the Punjab, Lahore, 54590, Pakistan. saima.sbb@pu.edu.pk.

المصدر: Annals of hematology [Ann Hematol] 2024 Feb; Vol. 103 (2), pp. 511-523. Date of Electronic Publication: 2023 Nov 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/genetics , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/metabolism , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/genetics, Child ; Humans ; Receptors, Notch/genetics ; Receptors, Notch/metabolism ; Signal Transduction/genetics ; DNA Methylation

المؤلفون: Dong Q; Department of Pathology, Case Western Reserve University, Cleveland, Ohio, USA., Darwish T; Department of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.; Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA., Howard M; Department of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.; Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA., Shetty S; Department of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.; Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA., Wang Y; Department of Pathology, Case Western Reserve University, Cleveland, Ohio, USA., Xiu Y; Department of Pathology, Case Western Reserve University, Cleveland, Ohio, USA., Gallogly M; Department of Hematology and Oncology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA., Zhao C; Department of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.; Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.; Department of Pathology, Louis Stokes Veterans Affairs Medical Center, Cleveland, Ohio, USA.

المصدر: The Journal of international medical research [J Int Med Res] 2024 Feb; Vol. 52 (2), pp. 3000605231156757.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Sage Publications Country of Publication: England NLM ID: 0346411 Publication Model: Print Cited Medium: Internet ISSN: 1473-2300 (Electronic) Linking ISSN: 03000605 NLM ISO Abbreviation: J Int Med Res Subsets: MEDLINE

مواضيع طبية MeSH: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/genetics , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/therapy , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/therapy , Leukemia, Myelogenous, Chronic, BCR-ABL Positive*, Humans ; T-Lymphocytes ; Philadelphia Chromosome

المؤلفون: Enlund S; Deparment of Women's and Children's Health, Division of Pediatric Oncology and Surgery, Karolinska Institutet, 171 77, Stockholm, Sweden., Sinha I; Deparment of Women's and Children's Health, Division of Pediatric Oncology and Surgery, Karolinska Institutet, 171 77, Stockholm, Sweden., Neofytou C; Department of Neuroscience, Karolinska Institutet, 171 77, Stockholm, Sweden., Amor AR; Deparment of Women's and Children's Health, Division of Pediatric Oncology and Surgery, Karolinska Institutet, 171 77, Stockholm, Sweden., Papadakis K; Deparment of Women's and Children's Health, Division of Pediatric Oncology and Surgery, Karolinska Institutet, 171 77, Stockholm, Sweden., Nilsson A; Deparment of Women's and Children's Health, Division of Pediatric Oncology and Surgery, Karolinska Institutet, 171 77, Stockholm, Sweden., Jiang Q; Division of Regenerative Medicine, Department of Medicine, Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA., Hermanson O; Department of Neuroscience, Karolinska Institutet, 171 77, Stockholm, Sweden., Holm F; Deparment of Women's and Children's Health, Division of Pediatric Oncology and Surgery, Karolinska Institutet, 171 77, Stockholm, Sweden. Electronic address: frida.holm@ki.se.

المصدر: Experimental cell research [Exp Cell Res] 2024 Apr 15; Vol. 437 (2), pp. 114015. Date of Electronic Publication: 2024 Mar 30.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0373226 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1090-2422 (Electronic) Linking ISSN: 00144827 NLM ISO Abbreviation: Exp Cell Res Subsets: MEDLINE

مواضيع طبية MeSH: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma* , Precursor Cell Lymphoblastic Leukemia-Lymphoma*, Child ; Humans ; Cell Survival ; T-Lymphocytes/metabolism ; Recurrence ; Cell Cycle ; Tumor Microenvironment

المؤلفون: Xiao M; Peking University People's Hospital, Peking University Institute of Hematology, Collaborative Innovation Center of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China., Zhou J; Peking University People's Hospital, Peking University Institute of Hematology, Collaborative Innovation Center of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China., Zhu X; Peking University People's Hospital, Peking University Institute of Hematology, Collaborative Innovation Center of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China., He Y; Peking University People's Hospital, Peking University Institute of Hematology, Collaborative Innovation Center of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China., Wang F; Peking University People's Hospital, Peking University Institute of Hematology, Collaborative Innovation Center of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China., Zhang Y; Peking University People's Hospital, Peking University Institute of Hematology, Collaborative Innovation Center of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China., Mo X; Peking University People's Hospital, Peking University Institute of Hematology, Collaborative Innovation Center of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China., Han W; Peking University People's Hospital, Peking University Institute of Hematology, Collaborative Innovation Center of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China., Wang J; Peking University People's Hospital, Peking University Institute of Hematology, Collaborative Innovation Center of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China., Wang Y; Peking University People's Hospital, Peking University Institute of Hematology, Collaborative Innovation Center of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China., Chen H; Peking University People's Hospital, Peking University Institute of Hematology, Collaborative Innovation Center of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China., Chen Y; Peking University People's Hospital, Peking University Institute of Hematology, Collaborative Innovation Center of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China., Zhao X; Peking University People's Hospital, Peking University Institute of Hematology, Collaborative Innovation Center of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China., Chang Y; Peking University People's Hospital, Peking University Institute of Hematology, Collaborative Innovation Center of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China., Xu L; Peking University People's Hospital, Peking University Institute of Hematology, Collaborative Innovation Center of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China., Liu K; Peking University People's Hospital, Peking University Institute of Hematology, Collaborative Innovation Center of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China., Huang X; Peking University People's Hospital, Peking University Institute of Hematology, Collaborative Innovation Center of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China., Zhang X; Peking University People's Hospital, Peking University Institute of Hematology, Collaborative Innovation Center of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China. zhangxh@bjmu.edu.cn.

المصدر: Bone marrow transplantation [Bone Marrow Transplant] 2024 Apr; Vol. 59 (4), pp. 496-504. Date of Electronic Publication: 2024 Jan 24.

نوع المنشور: Randomized Controlled Trial; Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation* , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/therapy , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/therapy, Humans ; Neoplasm, Residual/therapy ; Prognosis ; Retrospective Studies ; T-Lymphocytes

المؤلفون: Li D; Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, 325000, Zhejiang Province, China., Yuan Y; Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, 325000, Zhejiang Province, China., Meng C; Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, 325000, Zhejiang Province, China., Lin Z; Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, 325000, Zhejiang Province, China., Zhao M; Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, 325000, Zhejiang Province, China., Shi L; Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, Zhejiang Province, China., Li M; Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, 325000, Zhejiang Province, China., Ye D; Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, 325000, Zhejiang Province, China., Cai Y; Department of Clinical Medicine, Wenzhou Medical University, Chashan District, Wenzhou, Zhejiang Province, China., He X; Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, 325000, Zhejiang Province, China.; The Key Laboratory of Pediatric Hematology and Oncology Diseases of Wenzhou, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, 109 Xuanyuanxi Road, Wenzhou, Zhejiang Province, China., Ye H; Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, Zhejiang Province, China., Zhou S; Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, Zhejiang Province, China., Zhou H; The Key Laboratory of Pediatric Hematology and Oncology Diseases of Wenzhou, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, 109 Xuanyuanxi Road, Wenzhou, Zhejiang Province, China. zhxcrystal@126.com.; Department of Hematology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, 109 Xuanyuanxi Road, Wenzhou, Zhejiang Province, China. zhxcrystal@126.com., Gao S; Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, 325000, Zhejiang Province, China. gaoshenmeng77@wzhospital.cn.; The Key Laboratory of Pediatric Hematology and Oncology Diseases of Wenzhou, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, 109 Xuanyuanxi Road, Wenzhou, Zhejiang Province, China. gaoshenmeng77@wzhospital.cn.

المصدر: Clinical epigenetics [Clin Epigenetics] 2024 Mar 26; Vol. 16 (1), pp. 48. Date of Electronic Publication: 2024 Mar 26.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BiomedCentral Country of Publication: Germany NLM ID: 101516977 Publication Model: Electronic Cited Medium: Internet ISSN: 1868-7083 (Electronic) Linking ISSN: 18687075 NLM ISO Abbreviation: Clin Epigenetics Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents*/pharmacology , MicroRNAs*/genetics , MicroRNAs*/metabolism , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/genetics, Adult ; Animals ; Humans ; Mice ; Bridged Bicyclo Compounds, Heterocyclic/therapeutic use ; DNA Methylation/genetics ; Lymphocytes/metabolism ; Mice, Knockout ; Proto-Oncogene Proteins c-bcl-2/genetics ; Proto-Oncogene Proteins c-bcl-2/metabolism ; Sulfonamides/therapeutic use ; Homeodomain Proteins/genetics ; Homeodomain Proteins/metabolism ; Proto-Oncogene Proteins/genetics ; Proto-Oncogene Proteins/metabolism

المؤلفون: Parriott G; Committee on Immunology, University of Chicago, Chicago, IL, 60637, USA., Hegermiller E; Department of Pathology, University of Chicago, Chicago, IL, 60637, USA., Morman RE; Committee on Immunology, University of Chicago, Chicago, IL, 60637, USA.; Department of Pathology, University of Chicago, Chicago, IL, 60637, USA., Frank C; Department of Pathology, University of Chicago, Chicago, IL, 60637, USA., Saygin C; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, 60657, USA., Stock W; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, 60657, USA., Bartom ET; Department of Biochemistry and Molecular Genetics, Northwestern Feinberg School of Medicine, Chicago, IL, USA., Kee BL; Committee on Immunology, University of Chicago, Chicago, IL, 60637, USA. bkee@bsd.uchicago.edu.; Department of Pathology, University of Chicago, Chicago, IL, 60637, USA. bkee@bsd.uchicago.edu.; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, 60657, USA. bkee@bsd.uchicago.edu.; Department of Biochemistry and Molecular Genetics, Northwestern Feinberg School of Medicine, Chicago, IL, USA. bkee@bsd.uchicago.edu.

المصدر: Leukemia [Leukemia] 2024 Mar; Vol. 38 (3), pp. 491-501. Date of Electronic Publication: 2023 Dec 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

مواضيع طبية MeSH: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/genetics , Precursor Cell Lymphoblastic Leukemia-Lymphoma*, Mice ; Animals ; Transcription Factors/genetics ; Thymocytes/metabolism ; Thymus Gland/metabolism ; Cell Differentiation/genetics ; Basic Helix-Loop-Helix Transcription Factors/genetics

المؤلفون: Yanagi M; Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan. masatoyanagi0325@yahoo.co.jp.; Department of Hematology/Oncology for Children and Adolescents, Sapporo Hokuyu Hospital, Higashi-Sapporo 6-6, Shiroishi-ku, Sapporo, 003-0006, Japan. masatoyanagi0325@yahoo.co.jp., Mori M; Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan., Honda M; Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan., Mitani Y; Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan., Seki M; Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan., Fukuoka K; Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan., Oshima K; Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan., Arakawa Y; Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan., Koh K; Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.

المصدر: International journal of hematology [Int J Hematol] 2024 Mar; Vol. 119 (3), pp. 327-333. Date of Electronic Publication: 2024 Feb 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy , Lymphoma* , Hematopoietic Stem Cell Transplantation*/methods , Arabinonucleosides*, Humans ; Child ; Salvage Therapy ; Retrospective Studies ; T-Lymphocytes

المؤلفون: Song Y; Department of Bone Marrow Transplantation, Beijing Boren Hospital, Beijing, China., Liu Z; Department of Bone Marrow Transplantation, Beijing Boren Hospital, Beijing, China., Wang Q; Department of Bone Marrow Transplantation, Beijing Boren Hospital, Beijing, China., Gao K; Department of Bone Marrow Transplantation, Beijing Boren Hospital, Beijing, China., Wu T; Department of Bone Marrow Transplantation, Beijing Boren Hospital, Beijing, China.

المصدر: Frontiers in immunology [Front Immunol] 2024 Feb 28; Vol. 15, pp. 1333037. Date of Electronic Publication: 2024 Feb 28 (Print Publication: 2024).

نوع المنشور: Case Reports

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Receptors, Chimeric Antigen* , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma* , Hematopoietic Stem Cell Transplantation*/methods , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/therapy, Male ; Humans ; Child ; Quality of Life ; Acute Disease ; T-Lymphocytes